1-3 of 3
Katrine Fladeland Iversen
Close
Sort by
Journal Articles

Lenalidomide Maintenance in Multiple Myeloma: A Retrospective, Nationwide, Real-World Study

Mads Harsløf, Iman Chanchiri, Trine Silkjær, Ulf Christian Frølund, Elena Manuela Teodorescu, Kristina Buchardi Nielsen, Per Ishøy Nielsen, Per Trøllund Pedersen, Katrine Fladeland Iversen, Kirsten Grønbæk, Annette J. Vangsted, Sigrun Thorsteinsdottir, Agoston Gyula Szabo
Journal: Blood
Blood (2023) 142 (Supplement 1): 1979.
https://doi.org/10.1182/blood-2023-179074
Published: 2023
Journal Articles

Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody®-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

Andrew Spencer, Katrine Fladeland Iversen, Binod Dhakal, Maria Creignou, Jenny Chen, Ida H Hiemstra, Sieto Bosgra, Avani Badani, Esther C.W. Breij, Lauren K. Brady, A. Kate Sasser, Anders Malmberg, Henrik Gregersen, Markus Hansson, Annemiek Broijl, Maria-Victoria Mateos, Torben Plesner
Journal: Blood
Blood (2022) 140 (Supplement 1): 7320–7321.
https://doi.org/10.1182/blood-2022-159116
Published: 2022
Journal Articles

The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy

Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Noergaard Strandholdt, Mette Klarskov Andersen, Annette J. Vangsted
Journal: Blood
Blood (2021) 138 (Supplement 1): 3779.
https://doi.org/10.1182/blood-2021-152070
Published: 2021